Prognostication of survival in patients with advanced cancer: Predicting the unpredictable?

Cancer Control

Volumn 22, Issue 4, 2015, Pages 489-497

  Hui, David ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ADVANCED CANCER; ANOREXIA; ARTICLE; CACHEXIA; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL DECISION MAKING; DELIRIUM; DYSPHAGIA; DYSPNEA; EDEMA; GASTROINTESTINAL HEMORRHAGE; GLASGOW PROGNOSTIC SCORE; HEALTH CARE PERSONNEL; HUMAN; HYPERCALCEMIA; INFLAMMATION; KARNOFSKY PERFORMANCE STATUS; LEUKOCYTOSIS; LIFE EXPECTANCY; LUNG EMBOLISM; LYMPHOCYTOPENIA; MALNUTRITION; METABOLIC ACIDOSIS; PALLIATIVE PROGNOSTIC INDEX; PALLIATIVE PROGNOSTIC SCORE; PNEUMONIA; PREDICTION; PROBABILITY; PROGNOSIS; PROGNOSTIC ASSESSMENT; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SPINAL CORD COMPRESSION; SURVIVAL TIME; DECISION MAKING; MORTALITY; NEOPLASM; PALLIATIVE THERAPY; PATHOLOGY; PHYSIOLOGY; PROCEDURES;

DECISION MAKING; HUMANS; NEOPLASMS; PALLIATIVE CARE; PROGNOSIS;

EID: 84951771011     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327481502200415     Document Type: Article

References (90)

1. Weeks JC, Cook EF, O'Day SJ, et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA. 1998;279(21):1709-1714.
2. Temel JS, Greer JA, Admane S, et al. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol. 2011;29(17):2319-2326.
3. Hyman DM, Eaton AA, Gounder MM, et al. Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials. J Clin Oncol. 2014;32(6):519-526.
4. Pond GR, Siu LL, Moore M, et al. Nomograms to predict serious adverse events in phase II clinical trials of molecularly targeted agents. J Clin Oncol. 2008;26(8):1324-1330.
5. Miner TJ. Palliative surgery for advanced cancer: lessons learned in patient selection and outcome assessment. Am J Clin Oncol. 2005;28(4):411-414.
6. Casarett DJ, Fishman JM, Lu HL, et al. The terrible choice: re-evaluating hospice eligibility criteria for cancer. J Clin Oncol. 2009;27(6):953-959.
7. Lamont EB, Christakis NA. Physician factors in the timing of cancer patient referral to hospice palliative care. Cancer. 2002;94(10):2733-2737.
8. Hui D, Bruera E, eds. Internal Medicine Issues in Palliative Cancer Care. 1st ed. Oxford University Press, USA; 2014.
9. Lamont EB, Christakis NA. Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med. 2001;134(12):1096-1105.
10. Glare PA, Sinclair CT. Palliative medicine review: prognostication. J Palliat Med. 2008;11(1):84-103.
11. Hui D, Kilgore K, Nguyen L, et al. The accuracy of probabilistic versus temporal clinician prediction of survival for patients with advanced cancer: a preliminary report. Oncologist. 2011;16(11):1642-1648.
12. Llobera J, Esteva M, Rifa J, et al. Terminal cancer. duration and prediction of survival time. Eur J Cancer. 2000;36(16):2036-2043.
13. Hui D, dos Santos R, Reddy S, et al. Acute symptomatic complications among patients with advanced cancer admitted to acute palliative care units: A prospective observational study. Palliat Med. 2015;29(9):826-833.
14. Maltoni M, Caraceni A, Brunelli C, et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol. 2005;23(25):6240-6248.
15. Hui D, Dos Santos R, Chisholm G, et al. Bedside clinical signs associated with impending death in patients with advanced cancer: preliminary findings. Cancer. 2015;121(6):960-967.
16. Hui D, Dos Santos R, Chisholm G, et al. Clinical signs of impending death in cancer patients. Oncologist. 2014;19(6):681-687.
17. Hui D, Mori M, Parsons H, et al. The lack of standard definitions in the supportive and palliative oncology literature. J Pain Symptom Manage. 2012;43(3):582-592.
18. Hui D, Nooruddin Z, Didwaniya N, et al. Concepts and definitions for "actively dying," "end of life," "terminally ill," "terminal care," and "transition of care": a systematic review. J. Pain Symptom Manage. 2014;47(1):77-89.
19. Tripepi G, Jager KJ, Dekker FW, et al. Statistical methods for the assessment of prognostic biomarkers (part II): calibration and re-classification. Nephrol Dial Transplant. 2010;25(5):1402-1405.
20. Tripepi G, Jager KJ, Dekker FW, et al. Statistical methods for the assessment of prognostic biomarkers (Part I): discrimination. Nephrol Dial Transplant. 2010;25(5):1399-1401.
21. Steyerberg EW, Vergouwe Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J. 2014;35(29):1925-1931.
22. Steyerberg EW, Pencina MJ, Lingsma HF, et al. Assessing the incremental value of diagnostic and prognostic markers: a review and illustration. Eur J Clin Invest. 2012;42(2):216-228.
23. Cook NR, Paynter NP. Performance of reclassification statistics in comparing risk prediction models. Biom J. 2011;53(2):237-258.
24. Hosmer DW, Lemeshow S. Goodness of fit tests for the multiple logistic regression model. Commun Stat. 1980;A9(10):1043-1069.
25. Lemeshow S, Hosmer DW. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982;115(1):92-106.
26. Bruera E, Hui D. Practical model for prognostication in advanced cancer patients: is less more? J Clin Oncol. 2008;26(36):5843-5844.
27. Bruera S, Chisholm G, Dos Santos R, et al. Frequency and factors associated with unexpected death in an acute palliative care unit: expect the unexpected. J Pain Symptom Manage. 2015;49(5):822-827.
28. Casarett D. The median is not the (only) message. Ann Intern Med. 2006;145(9):700-701.
29. Moss AH, Lunney JR, Culp S, et al. Prognostic significance of the "surprise" question in cancer patients. J Palliat Med. 2010;13(7):837-840.
30. Perez-Cruz PE, Dos Santos R, Silva TB, et al. Longitudinal temporal and probabilistic prediction of survival in a cohort of patients with advanced cancer. J Pain Symptom Manage. 2014;48(5):875-882.
31. Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ. 2000;320(7233):469-472.
32. Moroni M, Zocchi D, Bolognesi D, et al. The 'surprise' question in advanced cancer patients: A prospective study among general practitioners. Palliat Med. 2014;28(7):959-964.
33. Hamano J, Morita T, Inoue S, et al. Surprise questions for survival prediction in patients with advanced cancer: a multicenter prospective cohort study. Oncologist. 2015;20(7):839-844.
34. Elliott M, Nicholson C. A qualitative study exploring use of the surprise question in the care of older people: perceptions of general practitioners and challenges for practice. BMJ Support Palliat Care. 2014. Epub ahead of print.
35. Kalia M. Biomarkers for personalized oncology: recent advances and future challenges. Metabolism. 2015;64(3 suppl 1):S16-S21.
36. Trajkovic-Vidakovic M, de Graeff A, Voest EE, et al. Symptoms tell it all: a systematic review of the value of symptom assessment to predict survival in advanced cancer patients. Crit Rev Oncol Hematol. 2012;84(1):130-148.
37. Hui D, Dos Santos RD, Chisholm GB, et al. Symptom expression in the last seven days of life among cancer patients admitted to acute palliative care units. J Pain Symptom Manage. 2015;50(4):488-494.
38. Seow H, Barbera L, Sutradhar R, et al. Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. J Clin Oncol. 2011;29(9):1151-1158.
39. Jang RW, Caraiscos VB, Swami N, et al. Simple prognostic model for patients with advanced cancer based on performance status. J Oncol Pract. 2014;10(5):e335-341.
40. University of Victory School of Health Information Science website. Prognostat. https://htg.his.uvic.ca/tools/PrognosticTools/PalliativePerformanceScale/ Prognostat/index.php. Accessed October 13, 2015.
41. Miladinovic B, Mhaskar R, Kumar A, et al. External validation of a web-based prognostic tool for predicting survival for patients in hospice care. J Palliat Care. 2013;29(3):140-146.
42. Mercadante S, Valle A, Porzio G, et al. Prognostic factors of survival in patients with advanced cancer admitted to home care. J Pain Symptom Manage. 2013;45(1):56-62.
43. Vashi PG, Gupta D, Lammersfeld CA, et al. The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy. Nutr J. 2013;12:118.
44. Tan CS, Read JA, Phan VH, et al. The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study. Support Care Cancer. 2015;23(2):385-391.
45. Sachlova M, Majek O, Tucek S. Prognostic value of scores based on malnutrition or systemic inflammatory response in patients with metastatic or recurrent gastric cancer. Nutr Cancer. 2014;66(8):1362-1370.
46. Martin L, Senesse P, Gioulbasanis I, et al. Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol. 2015;33(1):90-99.
47. Hui D, Bansal S, Morgado M, et al. Phase angle for prognostication of survival in patients with advanced cancer: preliminary findings. Cancer. 2014;120(14):2207-2214.
48. Caraceni A, Nanni O, Maltoni M, et al. Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer. 2000;89(5):1145-1149.
49. Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med. 2000;160(6):786-794.
50. Hui D, De La Cruz M, Bruera E. Palliative care for delirium in patients in the last weeks of life: the final frontier. J Palliat Care. 2014;30(4):259-264.
51. Vigano A, Bruera E, Jhangri GS, et al. Clinical survival predictors in patients with advanced cancer. Arch Intern Med. 2000;160(6):861-868.
52. Cuervo Pinna MA, Mota Vargas R, Redondo Moralo MJ, et al. Dyspnea-a bad prognosis symptom at the end of life. Am J Hosp Palliat Care. 2009;26(2):89-97.
53. Gupta D, Lammersfeld CA, Vashi PG, et al. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer. BMC Cancer. 2009;9:37.
54. Norman K, Stobaus N, Zocher D, et al. Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer. Am J Clin Nutr. 2010;92(3):612-619.
55. Li QQ, Lu ZH, Yang L, et al. Neutrophil count and the inflammationbased glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Asian Pac J Cancer Prev. 2014;15(2):945-950.
56. Suh SY, Ahn HY. Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study. Eur J Cancer. 2007;43(6):1051-1059.
57. Dev R, Hui D, Del Fabbro E, et al. Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer. Cancer. 2014;120(10):1586-1593.
58. Elsayem A, Mori M, Parsons HA, et al. Predictors of inpatient mortality in an acute palliative care unit at a comprehensive cancer center. Support Care Cancer. 2010;18(1):67-76.
59. Donovan PJ, Achong N, Griffin K, et al. PTHrP-mediated hypercalcemia: causes and survival in 138 patients. J Clin Endocrinol Metab. 2015;100(5):2024-2029.
60. Maltoni M, Nanni O, Pirovano M, et al; Italian Multicenter Study Group on Palliative Care. Successful validation of the palliative prognostic score in terminally ill cancer patients. J Pain Symptom Manage. 1999;17(4):240-247.
61. Pirovano M, Maltoni M, Nanni O, et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage. 1999;17(4):231-239.
62. Glare PA, Eychmueller S, McMahon P. Diagnostic accuracy of the palliative prognostic score in hospitalized patients with advanced cancer. J Clin. Oncol. 2004;22(23):4823-4828.
63. Tassinari D, Montanari L, Maltoni M, et al. The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy. Support Care Cancer. 2008;16(4):359-370.
64. McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 2008;67(3):257-262.
65. Hwang JE, Kim HN, Kim DE, et al. Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer. BMC Cancer. 2011;11:489.
66. Jeong JH, Lim SM, Yun JY, et al. Comparison of two inflammationbased prognostic scores in patients with unresectable advanced gastric cancer. Oncology. 2012;83(5):292-299.
67. Jiang AG, Lu HY. The Glasgow prognostic score as a prognostic factor in patients with advanced non-small cell lung cancer treated with cisplatin-based first-line chemotherapy. J Chemother. 2015;27(1):35-39.
68. Miura T, Matsumoto Y, Hama T, et al. Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study. Support Care Cancer. 2015;23(11):3149-3156.
69. Yoon SJ, Jung JG, Kim JS, et al. Retrospective assessment of objective prognostic score in terminally ill Korean patients with cancer. Am J Hosp Palliat Care. 2014;31(4):435-440.
70. Chuang RB, Hu WY, Chiu TY, et al. Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scale. J Pain Symptom Manage. 2004;28(2):115-122.
71. Al-Zahrani AS, El-Kashif AT, Mohammad AA, et al. Prediction of in-hospital mortality of patients with advanced cancer using the Chuang Prognostic Score. Am J Hosp Palliat Care. 2013;30(7):707-711.
72. Yun YH, Heo DS, Heo BY, et al. Development of terminal cancer prognostic score as an index in terminally ill cancer patients. Oncol Rep. 2001;8(4):795-800.
73. Bruera E, Miller MJ, Kuehn N, et al. Estimate of survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage. 1992;7(2):82-86.
74. Hung CY, Wang HM, Kao CY, et al. Magnitude of score change for the palliative prognostic index for survival prediction in patients with poor prognostic terminal cancer. Support Care Cancer. 2014;22(10):2725-2731.
75. Morita T, Tsunoda J, Inoue S, et al. The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer. 1999;7(3):128-133.
76. Sonoda H, Yamaguchi T, Matsumoto M, et al. Validation of the palliative prognostic index and palliative prognostic score in a palliative care consultation team setting for patients with advanced cancers in an acute care hospital in Japan. Am J Hosp Palliat Care. 2014;31(7):730-734.
77. Stone CA, Tiernan E, Dooley BA. Prospective validation of the palliative prognostic index in patients with cancer. J Pain Symptom Manage. 2008;35(6):617-622.
78. Alshemmari S, Ezzat H, Samir Z, et al. The palliative prognostic index for the prediction of survival and in-hospital mortality of patients with advanced cancer in Kuwait. J Palliat Med. 2012;15(2):200-204.
79. Subramaniam S, Thorns A, Ridout M, et al. Accuracy of prognosis prediction by PPI in hospice inpatients with cancer: a multi-centre prospective study. BMJ Support Palliat Care. 2013;3(3):324-329.
80. Hamano J, Kizawa Y, Maeno T, et al. Prospective clarification of the utility of the palliative prognostic index for patients with advanced cancer in the home care setting. Am J Hosp Palliat Care. 2014;31(8):820-824.
81. Scarpi E, Maltoni M, Miceli R, et al. Survival prediction for terminally ill cancer patients: revision of the palliative prognostic score with incorporation of delirium. Oncologist. 2011;16(12):1793-1799.
82. McMillan DC, Crozier JE, Canna K, et al. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis. 2007;22(8):881-886.
83. Suh SY, Choi YS, Shim JY, et al. Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study. Support Care Cancer. 2010;18(2):151-157.
84. Kelly L, White S, Stone PC. The B12/CRP index as a simple prognostic indicator in patients with advanced cancer: a confirmatory study. Ann Oncol. 2007;18(8):1395-1399.
85. Geissbuhler P, Mermillod B, Rapin CH. Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years. J Pain Symptom Manage. 2000;20(2):93-103.
86. Hyodo I, Morita T, Adachi I, et al. Development of a predicting tool for survival of terminally ill cancer patients. Jpn J Clin Oncol. 2010;40(5):442-448.
87. Maltoni M, Scarpi E, Pittureri C, et al. Prospective comparison of prognostic scores in palliative care cancer populations. Oncologist. 2012;17(3):446-454.
88. Stiel S, Bertram L, Neuhaus S, et al. Evaluation and comparison of two prognostic scores and the physicians' estimate of survival in terminally ill patients. Support Care Cancer. 2010;18(1):43-49.
89. Baba M, Maeda I, Morita T, et al. Survival prediction for advanced cancer patients in the real world: a comparison of the Palliative Prognostic Score, Delirium-Palliative Prognostic Score, Palliative Prognostic Index and modified Prognosis in Palliative Care Study predictor model. Eur J Cancer. 2015;51(12):1618-1629.
90. Kao CY, Hung YS, Wang HM, et al. Combination of initial palliative prognostic index and score change provides a better prognostic value for terminally ill cancer patients: a six-year observational cohort study. J Pain Symptom Manage. 2014;48(5):804-814.